Thunder Bay Regional Health Sciences
Welcome,         Profile    Billing    Logout  
 4 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vincent, Francois
PRIME, NCT03031821: Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

Terminated
3
168
Canada
Metformin, Placebo Oral Tablet, Placebo
Canadian Urologic Oncology Group, Prostate Cancer Canada, British Columbia Cancer Agency, BC Cancer Foundation
Prostate Cancer, Metabolic Syndrome
11/23
11/23
NCT04155034: S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Recruiting
3
668
Canada, US, RoW
Magnetic Resonance Imaging, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Prophylactic Cranial Irradiation, PCI
SWOG Cancer Research Network, National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
11/25
11/27
DASL-HiCaP, NCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Active, not recruiting
3
1100
Europe, Canada, US, RoW
Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog, External Beam Radiotherapy
University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, Cancer Trials Ireland, Canadian Cancer Trials Group, Memorial Sloan Kettering Cancer Center, Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/28
07/28
NCT05417516: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Recruiting
3
910
Canada, RoW
Whole Breast Irradiation (WBI), Partial Breast Irradiation (PBI)
Ontario Clinical Oncology Group (OCOG), GenesisCare AU
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
11/29
11/31
NCT02355171: Personalize My Treatment (PMT) Registry

Suspended
N/A
10000
Canada
Exactis Innovation
Cancer
12/24
 
ELISA, NCT04797299: Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

Recruiting
N/A
526
Canada
Ontario Clinical Oncology Group (OCOG)
DCIS
03/35
05/35
Theberge, Valerie
RHEAL, NCT04228991: Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Recruiting
3
588
Canada
Locoregional radiation treatment - Conventional fractionation, Locoregional radiation treatment - Hypofractionation
Ontario Clinical Oncology Group (OCOG)
Breast Neoplasms, Radiotherapy, Lymphedema
09/25
12/30
DEBRA, NCT04852887: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

Recruiting
3
1670
Canada, Japan, US, RoW
Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
NRG Oncology, National Cancer Institute (NCI)
Stage I Breast Cancer
01/26
07/41
TAILOR RT, NCT03488693: Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Recruiting
3
2140
Canada, US
Radiation, No Radiation
Canadian Cancer Trials Group, Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, NRG Oncology, SWOG Cancer Research Network
Breast Cancer
09/27
12/27
NCT05417516: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Recruiting
3
910
Canada, RoW
Whole Breast Irradiation (WBI), Partial Breast Irradiation (PBI)
Ontario Clinical Oncology Group (OCOG), GenesisCare AU
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
11/29
11/31
NCT03598257: Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

Active, not recruiting
2
300
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Survey Administration
National Cancer Institute (NCI)
Breast Inflammatory Carcinoma
06/27
06/27
ROSALIE, NCT05866458: Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

Recruiting
N/A
352
Canada
Ontario Clinical Oncology Group (OCOG)
Breast Cancer
10/31
10/31
Carvalho, Tatiana
NCT05417516: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Recruiting
3
910
Canada, RoW
Whole Breast Irradiation (WBI), Partial Breast Irradiation (PBI)
Ontario Clinical Oncology Group (OCOG), GenesisCare AU
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
11/29
11/31
Woo, Rachel
NCT05417516: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Recruiting
3
910
Canada, RoW
Whole Breast Irradiation (WBI), Partial Breast Irradiation (PBI)
Ontario Clinical Oncology Group (OCOG), GenesisCare AU
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
11/29
11/31
Macadangdang, Jemima
NCT05417516: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Recruiting
3
910
Canada, RoW
Whole Breast Irradiation (WBI), Partial Breast Irradiation (PBI)
Ontario Clinical Oncology Group (OCOG), GenesisCare AU
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
11/29
11/31

Download Options